Business Segments · R&D
Medical Devices — R&D
Abbott Medical Devices — R&D decreased by 3.5% to $444.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.7%, from $401.00M to $444.00M. Over 3 years (FY 2022 to FY 2025), Medical Devices — R&D shows an upward trend with a 9.7% CAGR.
Analysis
StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityStable
First reportedQ1 2022
Last reportedQ1 2026
Rolls up toR&D
How to read this metric
Higher spending indicates a commitment to long-term innovation, though it must be balanced against current profitability requirements.
Detailed definition
Represents the expenses incurred to discover, develop, and improve medical device products and technologies. This invest...
Peer comparison
Standard R&D expense metric for technology and healthcare companies.
Metric ID:
abt_segment_medical_devices_research_and_developmentHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $332.00M | $332.00M | $332.00M | $332.00M | $340.50M | $340.50M | $340.50M | $340.50M | $368.00M | $379.00M | $408.00M | $391.00M | $401.00M | $430.00M | $462.00M | $460.00M | $444.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +2.6% | +0.0% | +0.0% | +0.0% | +8.1% | +3.0% | +7.7% | -4.2% | +2.6% | +7.2% | +7.4% | -0.4% | -3.5% |
| YoY Change | — | — | — | — | +2.6% | +2.6% | +2.6% | +2.6% | +8.1% | +11.3% | +19.8% | +14.8% | +9.0% | +13.5% | +13.2% | +17.6% | +10.7% |
Range$332.00M – $462.00M
CAGR+7.5%
Avg YoY Growth+9.9%
Median YoY Growth+10.7%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Abbott's medical devices — r&d?
- Abbott (ABT) reported medical devices — r&d of $444.00M in Q1 2026.
- How has Abbott's medical devices — r&d changed year-over-year?
- Abbott's medical devices — r&d increased by 10.7% year-over-year, from $401.00M to $444.00M.
- What is the long-term trend for Abbott's medical devices — r&d?
- Over 3 years (2022 to 2025), Abbott's medical devices — r&d has grown at a 9.7% compound annual growth rate (CAGR), from $1.33B to $1.75B.
- What does medical devices — r&d mean?
- The total spending on developing new products and improving existing technologies.